SFC
XBI icon

Strategic Financial Concepts’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Strategic Financial Concepts’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-94,191
Closed -$14.9K – 748
2024
Q2 		$14.9K Buy
+94,191
New +$8.45M 0.01% 372

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Strategic Financial Concepts's XBI Position: Q3 2024 in Review

Strategic Financial Concepts sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 94,191 shares — an estimated $14.9K sold.

Strategic Financial Concepts first reported a position in XBI in Q2 2024 and held it in 1 quarter. The position peaked at $14.9K in Q2 2024. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

  • Strategic Financial Concepts reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
  • Strategic Financial Concepts sold 94,191 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $14.9K.
  • Strategic Financial Concepts first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and held it in 1 quarter.
  • Strategic Financial Concepts's State Street SPDR S&P Biotech ETF position peaked at $14.9K in Q2 2024.
  • 769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Strategic Financial Concepts's 13F filing for Q3 2024, filed 12 Nov 2024.